Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
1 other identifier
interventional
N/A
1 country
1
Brief Summary
In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedSeptember 28, 2006
September 1, 2006
September 13, 2005
September 25, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- type2 diabetes
- postprandial plasma glucose levels ≧180mg/dl
You may not qualify if:
- type1 diabetes
- AST(GOT) or ALT(GPT) ≧100IU/l
- creatinine ≧2.0mg/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Ibaraki, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Promotiom Group
Sanwa Kagaku Kenkyusho Co., Ltd.
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Last Updated
September 28, 2006
Record last verified: 2006-09